PT  - JOURNAL ARTICLE
AU  - Philippe Goupille
AU  - Naoual Harid
AU  - René-Marc Flipo
TI  - Axial Spondyloarthritis Disease Activity Cutoffs at Golimumab Initiation in the French GO-PRACTICE Study: Parallels With the German GO-NICE Study
AID  - 10.3899/jrheum.200172
DP  - 2020 Oct 15
TA  - The Journal of Rheumatology
PG  - jrheum.200172
4099  - http://www.jrheum.org/content/early/2020/10/13/jrheum.200172.short
4100  - http://www.jrheum.org/content/early/2020/10/13/jrheum.200172.full
AB  - Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disorder that includes both radiographic and nonradiographic entities1. International guidelines for axSpA management recommend nonsteroidal antiinflammatory drugs as the first line of treatment2,3